In a high-risk AML disease context, we achieved significant engraftment of malignant blast cells in various mouse organs, including BM, liver, and kidney, with these AML cells demonstrating high CD33 expression levels (Fig. 6b–d). The gene discussed is CD33; the disease is acute myeloid leukemia.